OrbusNeich® Announces China Approval for COMBO® Coronary Stent-PR Newswire APAC
- Written by PR Newswire
HONG KONG, Sept. 23, 2020 /PRNewswire/ -- OrbusNeich Medical Co. Ltd. has announced that the National Medical Products Administration (NMPA) has granted market approval for the COMBO BIO-ENGINEERED SIROLIMUS ELUTING STENT in China. It is the first dual therapy stent to both accelerate endothelial coverage and control neointimal proliferation...